Journal article

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

Sasha Bernatsky, Hector A Velasquez Garcia, John J Spinelli, Patrick Gaffney, Karin E Smedby, Rosalind Ramsey-Goldman, Sophia S Wang, Hans-Olov Adami, Demetrius Albanes, Emanuele Angelucci, Stephen M Ansell, Yan W Asmann, Nikolaus Becker, Yolanda Benavente, Sonja I Berndt, Kimberly A Bertrand, Brenda M Birmann, Heiner Boeing, Paolo Boffetta, Paige M Bracci Show all

Lupus Science & Medicine | BMJ PUBLISHING GROUP | Published : 2017


Awarded by U.S. Public Health Service from the National Cancer Institute, Department of Health and Human Services

Awarded by Bloodwise

Awarded by Fondation contre la

Awarded by National Cancer Institute

Funding Acknowledgements

Support for individual studiesATBC: The a-Tocopherol, II-Carotene Cancer Prevention Study is supported by the Intramural Research Program of the U.S. National Cancer Institute, National Institutes of Health and by U.S. Public Health Service contract HHSN261201500005C from the National Cancer Institute, Department of Health and Human Services.BC: Canadian Institutes for Health Research (CIHR); Canadian Cancer Society; Michael Smith Foundation for Health Research.CPS-II: The Cancer Prevention Study-II (CPS-II) Nutrition Cohort is supported by the American Cancer Society. Genotyping for all CPS-II samples were supported by the Intramural Research Program of the National Institutes of Health, NCI, Division of Cancer Epidemiology and Genetics. The authors would also like to acknowledge the contribution to this study from central cancer registries supported through the Centers for Disease Control and Prevention National Program of Cancer Registries and cancer registries supported by the National Cancer Institute Surveillance Epidemiology and End Results programme.ELCCS: Bloodwise (formerly Leukaemia & Lymphoma Research); grant reference 0073.ENGELA: Association pour la Recherche contre le Cancer (ARC), Institut National du Cancer (INCa), Fondation de France, Fondation contre la HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C and HHSN271201100004C.YALE: National Cancer Institute (CA62006); National Cancer Institute (CM 65923).